|Bid||7.90 x 1100|
|Ask||8.07 x 1400|
|Day's Range||7.57 - 8.30|
|52 Week Range||4.82 - 25.74|
|Beta (5Y Monthly)||0.49|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 26, 2024 - Mar 01, 2024|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||36.17|
Subscribe to Yahoo Finance Plus to view Fair Value for RNA
Avidity, Bristol Myers Squibb, Vertex, Arcturus and BioVie are included in this Analyst Blog.
Regulatory and pipeline updates from Avidity Biosciences, Inc. (RNA) and BioVie (BIVI) are in the spotlight this week.